The fully implanted Acclaim® cochlear implant received Breakthrough Device Designation from the FDA in 2019 and was first implanted in three participants during an early feasibility study (EFS) at ...
Medpage Today on MSN7d
Two Investigational Treatments for ALS Show Glimmer of HopeEach study randomized three patients to a treatment group for every control, leading to approximately 120 ALS patients ...
News Medical on MSN12d
National study underway to test new mechanical heart pumpA national clinical trial is underway to compare a novel mechanical heart pump to the only device currently used to treat end-stage heart failure. The INNOVATE study, led by University of Michigan, wi ...
Reprieve Cardiovascular, Inc., a development-stage company focused on advancing acute decompensated heart failure (ADHF) ...
Novo Nordisk announced plans for a longer phase III trial testing its investigational obesity drug CagriSema, with regulatory submission expected early next year. The FDA approved ranibizumab (Susvimo ...
Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...
A recent study published in the Clinical, Cosmetic and Investigational Dermatology journal revealed a significant link ...
Imunon (IMNN) announced new translational data from ongoing analyses of results from the Company’s Phase 2 OVATION 2 Study of IMNN-001, its ...
After an apparent accidental early release, Pfizer has revealed phase 1 data showing its investigational candidate, alongside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback